Omnes Capital's exits

Sector 
Mobile
Entry Date 
2000
Exit Date 
2005
Buyer 
Openwave
Business 
Venture Capital

Musiwave

Music-related services for mobiles

Development and marketing of music-related services for mobiles. The company is now part of the Microsoft group.

Sector 
SaaS / Cloud
Entry Date 
2003
Exit Date 
2005
Buyer 
Flextrade
Business 
Venture Capital

Traderforce

Financial data platforms

Financial data, trading systems, portfolio management and risk management platforms.

Sector 
SaaS / Cloud
Entry Date 
2003
Exit Date 
2005
Buyer 
IBM
Business 
Venture Capital

Meiosys

Application virtualisation specialist

Founded by former managers at Thomson CSF, Meiosys specialises in application virtualisation software and in peak workload.

Sector 
Web
Entry Date 
2000
Exit Date 
2004
Buyer 
IAC / Inter Active/Corp
Business 
Venture Capital

Egencia

Online business travel solutions

Online business travel offers and service solutions. The company is now part of the Expedia group.

Pages

NewsRoom
Publication
Omnes’ Environmental, Social and Governance (ESG) commitments
Press release
15 May 2019
SPHEREA continues its growth trajectory with a consortium comprising Andera Partners and Omnes
SPHEREA continues its growth trajectory with a consortium comprising Andera Partners and Omnes
Press release
09 May 2019
Camerus Group accelerates its growth strategy by acquiring Lign'Expo and completing an LBO with Bpifrance and Siparex Mezzanine, backed by Omnes, its existing investor

Camerus Group accelerates its growth strategy by acquiring Lign'Expo and completing an LBO with Bpifrance and Siparex Mezzanine, backed by Omnes, its existing investor
Press release
09 May 2019
360 onlineprint enters British market after attracting an investment of 20.4 million dollars
360 onlineprint enters British market after attracting an investment of 20.4 million dollars
Publication
Omnes Newsletter n°33: Analysis
Press release
11 April 2019
NH TherAguix, a start-up specializing in nanomedicine for cancer radiotherapy, announces a €13 million round of fundraising, led by Bpifrance

NH TherAguix, a start-up specializing in nanomedicine for cancer radiotherapy, announces a €13 million round of fundraising, led by Bpifrance

Pages